Liu, Lian;Erickson, Nicole Tonya;Ricard, Ingrid;von Weikersthal, Ludwig Fischer;Lerch, Markus M;Decker, Thomas;Kiani, Alexander;Kaiser, Florian;Heintges, Tobias;Kahl, Christoph;Kullmann, Frank;Scheithauer, Werner;Link, Hartmut;Höffkes, Heinz-Gert;Moehler, Markus;Gesenhues, Alena Britta;Theurich, Sebastian;Michl, Marlies;Modest, Dominik P;Algül, Hana;Stintzing, Sebastian;Heinemann, Volker;Holch, Julian W
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306).
Int J Cancer
2022
150
1
112-123

Heid, Irina;Trajkovic-Arsic, Marija;Lohöfer, Fabian;Kaissis, Georgios;Harder, Felix N;Mayer, Moritz;Topping, Geoffrey J;Jungmann, Friderike;Crone, Barbara;Wildgruber, Moritz;Karst, Uwe;Liotta, Lucia;Algül, Hana;Yen, Hsi-Yu;Steiger, Katja;Weichert, Wilko;Siveke, Jens T;Makowski, Marcus R;Braren, Rickmer F
Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularization.
Eur J Nucl Med Mol Imaging
2022
50
1
115-129